Christopher Colecchi is the Founding Managing Director of Broadview Ventures. See sector focus and contact routes.
Christopher Colecchi is the Founding Managing Director of Broadview Ventures, where he leads the investment team and operations while now serving in an advisory capacity to advance the firm’s strategy and mentor its team. Broadview Ventures focuses exclusively on early-stage companies developing technologies for the diagnosis and treatment of cardiovascular and neurovascular diseases, including cardiovascular disease and stroke. The firm typically invests at the seed and Series A stages across biotechnology, medical devices, diagnostics, and digital health, with a geographic focus on Boston-based or accessible startups. While specific check sizes and lead/follow behavior for Colecchi individually are not publicly detailed, Broadview’s tracked deals include investments up to $98 million in Series A rounds, such as NanoPhoria in October 2025. Colecchi serves on the boards of Ground Fluor Pharma (as Chairman), EP Sciences, and Aggamin, reflecting active involvement in his portfolio. His investment thesis centers on bridging the translational gap between scientific research and clinical application to improve human health. No distinctive public writing or un
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Christopher Colecchi · Full investor directory · Investor access · Company funding database